OTCMKTS:SVON (SVON) (SVON) Stock Price, News & Analysis → Charles Payne’s Gift to Stock Investors (From Unstoppable Prosperity) (Ad) Free SVON Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.29▼$0.3750-Day Range N/A52-Week Range$0.13▼$0.44Volume533,681 shsAverage Volume97,866 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (SVON) alerts: Email Address Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. About (SVON) Stock (OTCMKTS:SVON)Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Waltham, MA.Read More Ad InvestorPlaceElon’s New A.I. Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. SVON Stock News HeadlinesMarch 25, 2024 | theguardian.com‘I cried, it was beautiful’: Sven-Göran Eriksson fulfils his Liverpool dreamDecember 24, 2023 | msn.comSix most expensive homes sold in Avon, Dec. 11-17April 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.December 12, 2023 | finance.yahoo.comAdvanced Protective Gear and Armor Global Market Report 2023, Featuring Company Profiles of 3M, ArmorSource, Avon Protection DuPont and HoneywellDecember 8, 2023 | msn.com‘Bachelor in Paradise’ Season 9: Are Kylee Russell and Aven Jones Still Together?November 4, 2023 | msn.comAvon vs. Brecksville-Broadview Heights football: Eagles roll, 49-7, to regional semifinal roundSeptember 27, 2023 | msn.comAvon vs. Olmsted Falls volleyball: Eagles show resolve in four-set winJune 21, 2023 | news.yahoo.comWhen will Ukraine be accepted into NATO and what will happen next? - opinionApril 30, 2024 | Unstoppable Prosperity (Ad)Charles Payne’s Gift to Stock InvestorsRight now, millions of good honest folks are feeling the squeeze. Last year's terrible market did a number on their accounts. Stock values plunged. Retirement accounts lost too.June 11, 2023 | msn.comInside Air India’s Plan To Finance The Mammoth Aircraft OrderApril 14, 2023 | msn.comExpulsions, return, and gun reform: Wrapping up another wild week at the TN State CapitolApril 14, 2023 | msn.comTwo Columbus men arrested for threatening USPS worker with gun, stealing his keysApril 4, 2023 | msn.comCasino Night Fundraiser to Support Little Falls Education FoundationJanuary 30, 2023 | msn.com8 Adani group stocks stare at $1.5 billion outflows. Here are 4 scenariosJanuary 2, 2023 | msn.comElle Edwards' sister shares heartbreaking tribute to 'beautiful soul mate'November 30, 2022 | msn.comGeorgia’s first Nobu Hotel and Restaurant opens in BuckheadNovember 23, 2022 | msn.com“We definitely need a leader in our current 11” – Watford fan pundit issues Troy Deeney claim regarding Slaven Bilic’s squadOctober 28, 2022 | msn.comHomes in the Hamptons Are Selling for Record Prices and at Record SpeedOctober 12, 2022 | msn.com10 Overpowered Anime Villains (With One Big Weakness)August 20, 2022 | msn.comLOOK: Joint NFL practices lead to big-time Alabama reunionsAugust 9, 2022 | msn.comMeyers Manx Reimagines Its Groundbreaking ’60s-Era Buggy as a Beach-Ready EVSee More Headlines Receive SVON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (SVON) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/22/2017Today4/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:SVON CUSIPN/A CIK1035354 Webwww.eloxxpharma.com Phone(781) 577-5300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesSumit AggarwalPresident, Chief Executive Officer & DirectorNeil S. BelloffCOO, Secretary, EVP & General CounselDaniel E. GeffkenChief Financial OfficerThomas P. HavertyChief Medical OfficerVijay ModurHead-Research & DevelopmentKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors SVON Stock Analysis - Frequently Asked Questions How were (SVON)'s earnings last quarter? (SVON) (OTCMKTS:SVON) released its quarterly earnings data on Monday, May, 22nd. The company reported ($0.09) earnings per share for the quarter. What other stocks do shareholders of (SVON) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (SVON) investors own include Canopy Growth (WEED), Pulse Biosciences (PLSE), Inovio Pharmaceuticals (INO), Galectin Therapeutics (GALT), EMC (EMC), Check-Cap (CHEK) and Anavex Life Sciences (AVXL). This page (OTCMKTS:SVON) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingCharles Payne’s Gift to Stock InvestorsUnstoppable ProsperityHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmith4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (SVON) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
